Treating feeding intolerance with an enteral solution patterned after human amniotic fluid: A randomized, controlled, masked trial

Journal of Perinatology

Volumn 27, Issue 1, 2007, Pages 28-31

  Barney, C K ^a   Lambert, D K ^a   Alder, S C ^b   Scoffield, S H ^a   Schmutz, N ^a   Christensen, R D ^a  

^a McKay Dee Hospital Center   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALBUMIN; CYTOKINE; GROWTH FACTOR; HUMAN SERUM ALBUMIN; ISOTONIC SOLUTION; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SODIUM CHLORIDE;

AMNION FLUID; ARTICLE; ARTIFICIAL MILK; ATROPHY; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENTERIC FEEDING; GESTATIONAL AGE; HUMAN; MILK; NASOGASTRIC TUBE; NEWBORN INTENSIVE CARE; NUTRIENT SOLUTION; NUTRITIONAL INTOLERANCE; RANDOMIZED CONTROLLED TRIAL; SMALL INTESTINE MUCOSA; STATISTICAL ANALYSIS; TREATMENT DURATION;

AMNIOTIC FLUID; DOUBLE-BLIND METHOD; ENERGY INTAKE; ENTERAL NUTRITION; EPOETIN ALFA; FEEDING BEHAVIOR; FILGRASTIM; HUMANS; INFANT FORMULA; INFANT NUTRITION PHYSIOLOGY; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MILK, HUMAN; SINGLE-BLIND METHOD;

EID: 33845729415     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211609     Document Type: Article

References (20)

1. Jadcherla SR, Kliegman RM. Studies of feeding intolerance in very low birth weight infants: Definition and significance. Pediatrics 2002; 109: 516-517.
2. Berseth CL. Feeding methods for the preterm infant. Semin Neonatol 2001; 6: 417-424
3. Hernandez G, Velasco N, Wainstein C, Castillo L, Bugedo G, Maiz A et al. Gut mucosal atrophy after a short enteral fasting period in critically ill patients. J Crit Care 1999; 14: 73-77.
4. Barney CK, Purser N, Christensen RD. Treating feeding intolerance in the NICU by enterally administering a solution patterned after human amniotic fluid. Advan Neo Care 2006; 6: 89-95.
5. Calhoun DA, Juul SE, McBryde EV, Veerman MW, Christensen RD. Stability of filgrastim and epoetin alfa in a system designed for enteral administration in neonates. Ann Pharmacother 2000; 34: 1257-1261.
6. Calhoun DA, Richards BE, Gersting JA, Sullivan SE, Christensen RD. G-CSF and Epo stability in amniotic fluid during simulated in vitro digestion conditions. J Pharm Tech 2002; 18: 310-315.
7. Calhoun DA, Lunø M, Du Y, Christensen RD. Granulocyte colony-stimulating factor is present in human milk and its receptor is present in human fetal intestine. Pediatrics 2000; 105: E7.
8. Juul S, Joyce A, Zhao Y, Ledbetter D. Why is erythropoietin present in human milk? Studies on erythropoietin receptors on enterocytes of human and rat neonates. Pediatr Res 1999; 46: 263-268.
9. Juul SE, Christensen RD. Absorption of enteral recombinant human erythropoietin by neonates. Ann Pharmacother 2003; 37: 782-786.
10. Calhoun DA, Maheshwari A, Christensen RD. Recombinant granulocyte colony-stimulating factor administered enterally to neonates is not absorbed. Pediatrics 2003; 112: 421-423.
11. Sullivan SE, Calhoun DA, Maheshwari A, Ashmead TL, Aurebach DA, Hudak ML et al. Tolerance of simulated amniotic fluid in premature neonates. Ann Pharmacother 2002; 36: 1518-1524.
12. Lima-Rogel V, Calhoun DA, Maheshwari A, Torres-Montes A, Roque-Sanchez R, Garcia MG et al. Tolerance of a sterile isotonic electrolyte solution containing select recombinant growth factors in neonates recovering from necrotizing enterocolitis. J Perinatol 2003; 23: 200-204.
13. Lima-Rogel V, Ojeda MA, Villegas G, Torres-Montes A, Medrano S, Calhoun DA et al. Tolerance of an enterally administered simulated amniotic fluid-like solution by neonates recovering from surgery for congenital bowel abnormalities. J Perinatol 2004; 24: 295-298.
14. Christensen RD, Havraneck T, Gerstmann DR, Calhoun DA. Enteral administration of a simulated amniotic fluid to very low birth weight neonates. J Perinatol 2005; 25: 380-385.
15. Condino AA, Barleycorn AA, Lu W, Maheshwari A, Christensen RD, Calhoun DA. Abnormal intestinal histology in neonates with congenital anomalies of the gastrointestinal tract. Biol Neonate 2004; 85: 145-150.
16. Karnak I, Tanyel F, Muftuoglu S, Unsal I, Cakar N, Buyukpamukcu, N. Esophageal ligation: Effects on the development of fetal organic systems. Eur J Pediatr Surg 1996; 6: 328-333.
17. Trahair J, Harding R. Restitution of swallowing in the fetal sheep restores intestinal growth after midgestation esophageal obstruction. J Pediatr Gastroenterol Nutr 1995; 20: 156-161.
18. Maheshwari A. Role of cytokines in human intestinal villous development. Clin Perinatol 2004; 31: 143-156.
19. Juul SE. Recombinant erythropoietin as a neuroprotective treatment: In vitro and in vivo models. Clin Perinatol 2004; 31: 129-142.
20. Calhoun DA, Christensen RD. Hematopoietic growth factors in neonatal medicine: The use of enterally administered hematopoietic growth factors in the neonatal intensive care unit. Clin Perinatol 2004; 31: 169-182.